Merck's Covid-19 pill was cleared for use in the U.K., the first country to authorize the oral treatment shown to reduce hospitalization and death
developed by Merck & Co. with partner Ridgeback Biotherapeutics LP, becoming the first country to authorize the pill that can be taken at home and has been shown to reduce death and hospitalization in higher-risk patients.
The Merck-Ridgeback drug will give the U.K. a much-needed weapon against Covid-19 as winter approaches.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Factbox: Countries rush to buy Merck experimental COVID-19 pillMerck has signed eight deals to sell more than a total of 2 million courses of its experimental COVID-19 pill molnupiravir to governments around the world as countries scramble to tame the virus.
Read more »
Nearly 34,000 people were locked down at Shanghai Disney Resort, mass tested for COVID-19Following a single positive COVID result in the Chinese megacity on Sunday, Shanghai Disneyland was shut down for two days, and more than 30,000 people who had visited the sprawling theme park over the weekend were tracked down and tested for the disease
Read more »
CDC advisers to vote on giving Covid-19 vaccine to kids ages 5 to 11Millions of child-size doses of Pfizer's Covid-19 vaccine are being shipped from the company's facilities to distribution centers across the country -- ready to go out to pharmacies and pediatricians' offices, the Biden administration said Monday. They're just waiting for the OK from the US Centers for Disease Control and Prevention, whose independent advisers will vote Tuesday on whether to recommend Covid-19 vaccines for 5- to 11-year-olds.
Read more »
Pfizer raises COVID-19 vaccine sales forecast to $36 bln for 2021Pfizer Inc on Tuesday raised the full-year sales forecast for its COVID-19 vaccine by 7.5% to $36 billion, as it signs deals with countries for booster doses and receives clearances for using its shots in broader age groups.
Read more »
Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 blnPfizer Inc on Tuesday said it expected this year to sell $36 billion of the COVID-19 vaccine it developed with German partner BioNTech and forecast another $29 billion in sales in 2022, topping analyst estimates for both years.
Read more »
New CDC Covid-19 Warnings: Avoid Travel To Russia, Belgium, Slovakia, Burkina FasoAdditionally, Poland went from moderate to high Covid-19 risk. But situations in Fiji and Jamaica have improved.
Read more »